France: Ready for Ebola

With strong links with the West Coast of Africa, France is among countries most likely to experience Ebola, with an estimated 20% chance of cases in the homeland before October ends - a few suspected cases have arisen.

Photo: France: Ready for Ebola
Source: WHO /Stéphane Saporito

On daily flights to France from Conakry, Guinea, questionnaires record passengers’ destinations for later contact if necessary. Disembarked, they also undergo checks by Red Cross and Civil Protection Unit medics.

President François Hollande has announced that France would help the Guineans to build more anti-Ebola treatment centres (one is already constructed in Macenta), and French Civil Protection personnel will be deployed for training purposes.

The Bégin military hospital has 60 staff highly trained in infectious diseases and intensive care and has successfully used an experimental treatment for a Médecins Sans Frontières nurse who caught Ebola in Liberia.

Two other Paris hospitals and 12 French reference hospitals are also ready to handle cases.

In a patient’s negative pressure room, all initial laboratory tests are performed at the bedside in a specialised mini-laboratory. Results from samples sent to Lyon for analysis at the central high security reference laboratory, come within six hours

30.10.2014

Read all latest stories

Related articles

Photo

Sponsored • Disease management

Multiplex Testing: A Solution to Manage Surge in Respiratory Illnesses as Concerns over “Multi-demic” Rise

Eunsin Bae, M.D. specializes in laboratory medicine and leads the Institute of Clinical Research at Seegene Inc. Her research focuses on microbiology, molecular biology, and hematology. Dr. Bae is…

Photo

News • Coronavirus mechanism discovered

Organ-on-a-chip reveals how SARS-CoV-2 invades blood vessels

A research group has revealed that SARS-CoV-2 disrupts the vascular endothelial barrier by suppressing the expression of Claudin-5 (CLDN5) to invade the blood vessels.

Photo

News • Deep mutational scanning for SARS-CoV-2

Preparing rapid tests for future coronavirus variants

How can rapid antigen tests be adjusted to reliably detect future variants of SARS-CoV-2? A research team funded by the National Institutes of Health is currently working on finding an answer.

Related products

Siemens Healthineers – Fast Track Real-time PCR assays

Infectious Disease

Siemens Healthineers – Fast Track Real-time PCR assays

Siemens Healthcare GmbH
Alsachim - Dosimmune immunosupressant Alsachim – kit (CE-IVD or RUO)

Clinical Chemistry

Alsachim - Dosimmune immunosupressant Alsachim – kit (CE-IVD or RUO)

Alsachim, a Shimadzu Group Company
Alsachim – Dosimyco immunosupressant reagent kit (RUO)

Clinical Chemistry

Alsachim – Dosimyco immunosupressant reagent kit (RUO)

Alsachim, a Shimadzu Group Company
Alsachim – Dosinaco anticoagulant reagent kit (RUO)

Clinical Chemistry

Alsachim – Dosinaco anticoagulant reagent kit (RUO)

Alsachim, a Shimadzu Group Company
ASP Lab Automation – SortPro Sample sorter

Sample Processing

ASP Lab Automation – SortPro Sample sorter

ASP Lab Automation AG
Subscribe to Newsletter